Dauplat J, Ferrière J P, Gorbinet M, Legros M, Chollet P, Giraud B, Plagne R
Presse Med. 1986 Sep 13;15(29):1351-4.
Seventy-one patients with advanced epithelial ovarian carcinoma were treated at the Centre Jean Perrin between May 1979 and December 1983. Following an initial laparotomy performed for staging and maximum cytoreductive surgery, six to twelve courses of chemotherapy were delivered with cis-platinum; 43 patients underwent a second look operation (S.L.O.). The results of initial surgery, chemotherapy and S.L.O. are discussed: survival rate is 57% at 3 years for stage III. 38% complete remission induced by chemotherapy were proved by negative S.L.O. after primary surgery with residual disease. Initial complete debulking and negative S.L.O. were significant factors that improved prognosis. Improvement of survival expectancy by removal of all macroscopic residual disease at S.L.O. remains to be proved. Treatment after S.L.O. is still under discussion.
1979年5月至1983年12月期间,让·佩兰中心对71例晚期上皮性卵巢癌患者进行了治疗。在进行了用于分期和最大限度肿瘤细胞减灭术的初次剖腹手术后,使用顺铂进行了6至12个疗程的化疗;43例患者接受了二次探查手术(S.L.O.)。讨论了初次手术、化疗和二次探查手术的结果:Ⅲ期患者3年生存率为57%。在初次手术后有残留病灶的患者中,二次探查手术结果为阴性,证实化疗诱导的完全缓解率为38%。初次完全减瘤和二次探查手术结果为阴性是改善预后的重要因素。通过二次探查手术切除所有肉眼可见的残留病灶来提高预期生存率仍有待证实。二次探查手术后的治疗仍在讨论中。